The FDA’s recent rejection of a so-called female Viagra illustrates the divide between doctors on how to detect and treat low sexual desire in women, or if there is even any need to do so.
A “little pink pill” to sol ve women’s sexual problems probably won’t be hitting drugstore shelves anytime soon. But that doesn’t mean discussion of the need for it, or lack thereof, is likely to end. (Source: (more…)
On Friday, an FDA advisory panel voted 11-0 against recommending FDA approval of a proposed treatment for hypoactive sexual-desire disorder, which decreases women’s sex drive, the Wall Street Journal reports. The R eproductive Health Drugs Advisory Committee reviewed an application seeking FDA approval of the drug flibanserin, also known as the “pink pill” or “female Viagra.” Although the agency is not required to follow the panel’s recommendation, (more…)
Claims that the development of a drug to treat female sexual dysfunction amounts to “disease mongering” come “down to a delicate judgment call — that lack of female sexual satisfaction isn’t really a problem,” Washing ton Post columnist Katrina vanden Heuvel writes. On June 18, an FDA advisory committee is scheduled to consider whether to recommend approval of flibanserin — “the so-called pink Viagra” — as a treatment for hypoactive sexual (more…)
Title: Taking Viagra Won’t Spur Risky Sexual BehaviorCategory: Health NewsCreated: 1/13/2010 12:10:00 PMLast Editorial Review: 1/14/2010 (Source: MedicineNet Mens Health General)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.
The drug sildenafil (Viagra, Pfizer) and, more recently, tadalafil (Cialis, Lilly-Icos) and vardenafil (Levitra, Bayer), has drawn public attention to aphrodisiacs. The search for such substances dates back millennia. Adverse effects associated with these … (Source: SafetyLit: All (Unduplicated))
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 fre e advertising.
The FDA announced this week that Atlas Operations has initi ated a recall of their dietary supplements marketed for “male enhancement”. Analysis revealed that some of the products contained sulfoaildenafil, a sildenaf il analogue. Â This drug has the potential to cause dangerous decreases in blood pressure, especially for patients taking certain other medications such as nitroglycerin. Â According to a press release from the company, (more…)
Title: Taking Viagra Won’t Spur Risky Sexual BehaviorCategory: Health NewsCreated: 1/13/2010 12:10:00 PMLast Editorial Review: 1/14/2010 (Source: MedicineNet Senior Health General)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.
Istanbul, Turkey–The phosphodiesterase type-5 inhibitor vardenafil (Levitra) significantly impr oves
sexual pleasure and treatment satisfaction in both men with erectile dysfunction and their partners, according to
study results presented at the European Association of Urology annual congress here. (Source: UrologyTimes – Sexual Dysfunction)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and (more…)
TORONTO (MARKET WIRE) Nutrabiosys Inc. (PINKSHEETS: NTBS) has developed an all natural herbal formulated alternative to Viagra(TM), Cialis(TM) and other widely used prescription drugs. In early testing the product has produced similar results as other prescribed sexual enhancement medications without the adverse sid e effects. The all natural herbal supplement will be produced and marketed under the name NuVtra. (Source: Market Wire – Pharmaceuticals (more…)
Do you think the three available phosphodiesterase type-5 inhibitors-vardenafil hydrochloride
(Levitra), tadalafil (Cialis), and sildenafil citrate (Viagra)-are essentially the same, or do th ey have distinct
advantages in the treatment of ED? (Source: UrologyTimes – Sexual Dysfunction)
MedWorm Message: Register forMedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.